Vancomycin for MRSA: Why Clinicians Are Reconsidering the Gold Standard in 2026 Key Takeaways For decades, vancomycin has served as the cornerstone of treatment for infections caused by methicillin resistant Staphylococcus aureus (MRSA). Its widespread adoption established it as the default empiric therapy across a broad range of clinical
Tag: MRSA
